+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Disease Management Market by Disease Type, Product Type, End User, Care Type, Delivery Mode - Global Forecast 2025-2030- Product Image
Chronic Disease Management Market by Disease Type, Product Type, End User, Care Type, Delivery Mode - Global Forecast 2025-2030- Product Image
Sale

Chronic Disease Management Market by Disease Type, Product Type, End User, Care Type, Delivery Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010859
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chronic Disease Management Market grew from USD 9.33 billion in 2023 to USD 10.12 billion in 2024. It is expected to continue growing at a CAGR of 7.10%, reaching USD 15.09 billion by 2030.

Chronic Disease Management (CDM) refers to the coordinated care efforts designed to improve health outcomes for individuals with long-term health conditions such as diabetes, heart disease, and COPD. The necessity of CDM arises from the increasing prevalence of chronic diseases due to an aging global population, lifestyle changes, and rising healthcare costs. Its application spans telemedicine, remote monitoring, and personalized medicine, empowering patients and providers to manage conditions more effectively. End-use scope includes hospitals, clinics, home healthcare, and digital health platforms. Key factors influencing market growth include advancements in healthcare technology, increasing awareness of preventive care, and supportive governmental policies promoting chronic disease management programs. The latest opportunities lie in digital health solutions, such as AI-driven diagnostic tools and data analytics for patient care optimization, offering personalized treatment plans and predictive health insights. Adoption of wearable technology and remote patient monitoring also presents new avenues for growth by facilitating continuous management and reducing hospital readmissions. Nevertheless, limited healthcare infrastructure in developing regions, regulatory hurdles, high costs of advanced management tools, and data privacy concerns pose significant challenges to market expansion. Innovations in artificial intelligence, machine learning, and big data analytics provide promising areas for research and development, enabling proactive disease management and paving the way for cost-effective solutions. Businesses could capitalize on these opportunities by forming strategic partnerships with technology companies, investing in consumer engagement platforms, and focusing on enhancing interoperability of health systems. The nature of the market is highly competitive and continually evolving, with key players seeking to differentiate through innovation and customer experience. Addressing barriers to adoption and ensuring alignment with regulatory standards will be crucial for sustained growth in the CDM sector.

Understanding Market Dynamics in the Chronic Disease Management Market

The Chronic Disease Management Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
    • Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
    • Growing awareness among healthcare providers and patients about the importance of chronic disease management
    • Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
  • Market Restraints
    • High cost associated with advanced treatments, technologies, and long-term care
    • Concerns over data breaches, unauthorized access, and loss of sensitive patient information
  • Market Opportunities
    • Expansion of mobile health platforms addressing chronic disease management in underserved communities
    • Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
    • Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
  • Market Challenges
    • Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
    • Difficulties in ensuring patients adherence to their prescribed treatment plans

Exploring Porter’s Five Forces for the Chronic Disease Management Market

Porter’s Five Forces framework further strengthens the insights of the Chronic Disease Management Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Chronic Disease Management Market

External macro-environmental factors deeply influence the performance of the Chronic Disease Management Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Chronic Disease Management Market

The Chronic Disease Management Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Chronic Disease Management Market

The Chronic Disease Management Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Chronic Disease Management Market

The Chronic Disease Management Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Disease Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, Glooko, Inc., Health Catalyst Inc., Hinge Health, Inc., Lark Technologies, Inc., Livongo Health, Inc., Medtronic plc, Merck & Co., Inc., MySugr GmbH, Novo Nordisk A/S, Omada Health, Inc., Propeller Health, Roche Holding AG, Sanofi S.A., Virta Health Corp., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Disease Management Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Disease Type
    • Cancer
    • Cardiovascular Diseases
    • Chronic Kidney Diseases
    • Chronic Respiratory Diseases
    • Diabetes
  • Product Type
    • Devices
      • Diagnostic Devices
      • Monitoring Devices
      • Therapeutic Devices
    • Drugs
      • Analgesics
      • Antihypertensive
      • Bronchodilators
      • Insulin
    • Services
      • Home Healthcare
      • Telemedicine
  • End User
    • Clinics
    • Homecare Settings
    • Hospitals
    • Long-term Care Centers
  • Care Type
    • Professional Care
    • Self-care
  • Delivery Mode
    • Cloud-based
    • On-premise
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
5.1.1.2. Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
5.1.1.3. Growing awareness among healthcare providers and patients about the importance of chronic disease management
5.1.1.4. Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
5.1.2. Restraints
5.1.2.1. High cost associated with advanced treatments, technologies, and long-term care
5.1.2.2. Concerns over data breaches, unauthorized access, and loss of sensitive patient information
5.1.3. Opportunities
5.1.3.1. Expansion of mobile health platforms addressing chronic disease management in underserved communities
5.1.3.2. Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
5.1.3.3. Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
5.1.4. Challenges
5.1.4.1. Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
5.1.4.2. Difficulties in ensuring patients adherence to their prescribed treatment plans
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Chronic Disease Management Market, by Disease Type
6.1. Introduction
6.2. Cancer
6.3. Cardiovascular Diseases
6.4. Chronic Kidney Diseases
6.5. Chronic Respiratory Diseases
6.6. Diabetes
7. Chronic Disease Management Market, by Product Type
7.1. Introduction
7.2. Devices
7.2.1. Diagnostic Devices
7.2.2. Monitoring Devices
7.2.3. Therapeutic Devices
7.3. Drugs
7.3.1. Analgesics
7.3.2. Antihypertensive
7.3.3. Bronchodilators
7.3.4. Insulin
7.4. Services
7.4.1. Home Healthcare
7.4.2. Telemedicine
8. Chronic Disease Management Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Homecare Settings
8.4. Hospitals
8.5. Long-term Care Centers
9. Chronic Disease Management Market, by Care Type
9.1. Introduction
9.2. Professional Care
9.3. Self-care
10. Chronic Disease Management Market, by Delivery Mode
10.1. Introduction
10.2. Cloud-based
10.3. On-premise
11. Americas Chronic Disease Management Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Chronic Disease Management Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Chronic Disease Management Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CHRONIC DISEASE MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CHRONIC DISEASE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CHRONIC DISEASE MANAGEMENT MARKET DYNAMICS
TABLE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 65. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 107. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 108. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 110. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 111. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 114. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 115. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 119. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 131. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 134. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 135. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 138. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 179. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 182. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 183. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 186. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 204. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 212. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 228. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 236. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 239. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 241. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 243. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 252. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 253. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 255. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 256. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 259. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 276. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 279. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 281. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 283. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 284. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 285. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 287. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 288. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 289. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 292. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 295. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 297. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 299. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 324. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 325. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 327. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 328. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 329. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
TABLE 331. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 333.

Companies Mentioned

The leading players in the Chronic Disease Management market, which are profiled in this report, include:
  • Abbott Laboratories
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • DexCom, Inc.
  • Eli Lilly and Company
  • Glooko, Inc.
  • Health Catalyst Inc.
  • Hinge Health, Inc.
  • Lark Technologies, Inc.
  • Livongo Health, Inc.
  • Medtronic plc
  • Merck & Co., Inc.
  • MySugr GmbH
  • Novo Nordisk A/S
  • Omada Health, Inc.
  • Propeller Health
  • Roche Holding AG
  • Sanofi S.A.
  • Virta Health Corp.
  • Welldoc, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.09 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Chronic Disease Management Global Market Report 2024 - Product Image

Chronic Disease Management Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Chronic Disease Management Market 2024-2028 - Product Image

Chronic Disease Management Market 2024-2028

  • Report
  • 153 Pages
  • Global
From
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets - Product Image

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

  • Report
  • 157 Pages
  • Global
From
Disease Management Apps Global Market Report 2024 - Product Image

Disease Management Apps Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Disease Management Apps Market Size, Share & Trends Analysis Report by Platform Type (iOS, Android), Device (Smartphone, Tablet), Indication (Obesity, Cardiovascular Issues), Region, and Segment Forecasts, 2024-2030 - Product Image

Disease Management Apps Market Size, Share & Trends Analysis Report by Platform Type (iOS, Android), Device (Smartphone, Tablet), Indication (Obesity, Cardiovascular Issues), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From

About the Chronic Disease Management Market

Chronic Disease Management (CDM) is a healthcare strategy that focuses on the prevention, diagnosis, and treatment of chronic diseases. It is a key component of managed care, which is a system of healthcare delivery that emphasizes preventive care, cost containment, and quality improvement. CDM is designed to improve patient outcomes and reduce healthcare costs by providing comprehensive, coordinated care for individuals with chronic conditions. This includes patient education, lifestyle modification, and medication management. CDM also includes the use of evidence-based guidelines, health information technology, and population health management to improve care coordination and quality. Some companies in the CDM market include Health Catalyst, Cerner Corporation, Allscripts, McKesson Corporation, and Optum. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.